188 related articles for article (PubMed ID: 37778390)
21. Assessment of the Diagnostic Value of Plasma Levels, Activities, and Their Ratios of von Willebrand Factor and ADAMTS13 in Patients with Cerebral Infarction.
Qu L; Jiang M; Qiu W; Lu S; Zhao Y; Xia L; Ruan C; Zhao Y
Clin Appl Thromb Hemost; 2016 Apr; 22(3):252-9. PubMed ID: 25916953
[TBL] [Abstract][Full Text] [Related]
22. The role of protein arginine deiminase 4-dependent neutrophil extracellular traps formation in ulcerative colitis.
Wang P; Liu D; Zhou Z; Liu F; Shen Y; You Q; Lu S; Wu J
Front Immunol; 2023; 14():1144976. PubMed ID: 37143672
[TBL] [Abstract][Full Text] [Related]
23. An unbiased proteomic analysis of PAD4 in human monocytes: novel substrates, binding partners and subcellular localizations.
Thomas MA; Kim SY; Curran AM; Smith B; Antiochos B; Na CH; Darrah E
Philos Trans R Soc Lond B Biol Sci; 2023 Nov; 378(1890):20220477. PubMed ID: 37778379
[TBL] [Abstract][Full Text] [Related]
24. Peptidylarginine deiminase expression and activity in PAD2 knock-out and PAD4-low mice.
van Beers JJ; Zendman AJ; Raijmakers R; Stammen-Vogelzangs J; Pruijn GJ
Biochimie; 2013 Feb; 95(2):299-308. PubMed ID: 23026755
[TBL] [Abstract][Full Text] [Related]
25. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
[TBL] [Abstract][Full Text] [Related]
26. Citrullination Licenses Calpain to Decondense Nuclei in Neutrophil Extracellular Trap Formation.
Gößwein S; Lindemann A; Mahajan A; Maueröder C; Martini E; Patankar J; Schett G; Becker C; Wirtz S; Naumann-Bartsch N; Bianchi ME; Greer PA; Lochnit G; Herrmann M; Neurath MF; Leppkes M
Front Immunol; 2019; 10():2481. PubMed ID: 31695698
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of von Willebrand factor scissile bond cleavage by a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13).
Xiang Y; de Groot R; Crawley JT; Lane DA
Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11602-7. PubMed ID: 21705658
[TBL] [Abstract][Full Text] [Related]
28. Myeloid-Specific Deletion of Peptidylarginine Deiminase 4 Mitigates Atherosclerosis.
Liu Y; Carmona-Rivera C; Moore E; Seto NL; Knight JS; Pryor M; Yang ZH; Hemmers S; Remaley AT; Mowen KA; Kaplan MJ
Front Immunol; 2018; 9():1680. PubMed ID: 30140264
[TBL] [Abstract][Full Text] [Related]
29. Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W.
Pruss CM; Golder M; Bryant A; Hegadorn C; Haberichter S; Lillicrap D
J Thromb Haemost; 2012 May; 10(5):940-50. PubMed ID: 22372972
[TBL] [Abstract][Full Text] [Related]
30. MiR-155 Regulates PAD4-Dependent Formation of Neutrophil Extracellular Traps.
Hawez A; Al-Haidari A; Madhi R; Rahman M; Thorlacius H
Front Immunol; 2019; 10():2462. PubMed ID: 31736940
[TBL] [Abstract][Full Text] [Related]
31. Altered von Willebrand Factor and ADAMTS13 Levels in Children With Cirrhosis and Extrahepatic Portal Hypertension.
Islek A; Ilhan D; Ozturk N; Guven B; Sag E
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e951-e956. PubMed ID: 33369998
[TBL] [Abstract][Full Text] [Related]
32. The role of ADAMTS13 in acute myocardial infarction: cause or consequence?
Eerenberg ES; Teunissen PF; van den Born BJ; Meijers JC; Hollander MR; Jansen M; Tijssen R; Beliën JA; van de Ven PM; Aly MF; Kamp O; Niessen HW; Kamphuisen PW; Levi M; van Royen N
Cardiovasc Res; 2016 Aug; 111(3):194-203. PubMed ID: 27174213
[TBL] [Abstract][Full Text] [Related]
33. Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality.
Sinkovits G; Réti M; Müller V; Iványi Z; Gál J; Gopcsa L; Reményi P; Szathmáry B; Lakatos B; Szlávik J; Bobek I; Prohászka ZZ; Förhécz Z; Mező B; Csuka D; Hurler L; Kajdácsi E; Cervenak L; Kiszel P; Masszi T; Vályi-Nagy I; Prohászka Z
Thromb Haemost; 2022 Feb; 122(2):240-256. PubMed ID: 35062036
[TBL] [Abstract][Full Text] [Related]
34. Protein arginine deiminase 4 inactivates tissue factor pathway inhibitor-alpha by enzymatic modification of functional arginine residues.
Thomassen MCLGD; Bouwens BRC; Wichapong K; Suylen DP; Bouwman FG; Hackeng TM; Koenen RR
J Thromb Haemost; 2023 May; 21(5):1214-1226. PubMed ID: 36716968
[TBL] [Abstract][Full Text] [Related]
35. The p.R1819_C1948delinsS mutation makes von Willebrand factor ADAMTS13-resistant and reduces its collagen-binding capacity.
Daidone V; Saga G; Barbon G; Pontara E; Cattini MG; Morpurgo M; Zanotti G; Casonato A
Br J Haematol; 2015 Aug; 170(4):564-73. PubMed ID: 25904363
[TBL] [Abstract][Full Text] [Related]
36. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
[TBL] [Abstract][Full Text] [Related]
37. Thrombosis and von Willebrand Factor.
Shahidi M
Adv Exp Med Biol; 2017; 906():285-306. PubMed ID: 27628010
[TBL] [Abstract][Full Text] [Related]
38. PADs and NETs in digestive system: From physiology to pathology.
Song YH; Wang ZJ; Kang L; He ZX; Zhao SB; Fang X; Li ZS; Wang SL; Bai Y
Front Immunol; 2023; 14():1077041. PubMed ID: 36761761
[TBL] [Abstract][Full Text] [Related]
39. Binding of ADAMTS13 to von Willebrand factor.
Majerus EM; Anderson PJ; Sadler JE
J Biol Chem; 2005 Jun; 280(23):21773-8. PubMed ID: 15824096
[TBL] [Abstract][Full Text] [Related]
40. Changes in von Willebrand factor and ADAMTS-13 in patients following arthroplasty.
Liu L; Ling J; Ma Z; Yuan Q; Pan J; Yang H
Mol Med Rep; 2015 Apr; 11(4):3015-20. PubMed ID: 25482054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
